Related Experiment Videos

Mannan binding lectin and the sudden infant death syndrome

D C Kilpatrick1, V S James, C C Blackwell

  • 1Academic Unit, Blood Transfusion Service, Edinburgh, UK.

Insights

Mannan-binding lectin (MBL) deficiency may not increase sudden infant death syndrome (SIDS) risk. However, higher MBL levels in SIDS infants suggest preceding bacterial infections may play a role in cot deaths.

Area of Science:

  • Immunology
  • Pediatrics
  • Pathology

Background:

  • Mannan-binding lectin (MBL) is crucial for innate immunity.
  • Sudden infant death syndrome (SIDS) may be linked to bacterial infections.
  • MBL deficiency could potentially increase SIDS susceptibility.

Purpose of the Study:

  • To investigate the association between MBL concentrations and SIDS.
  • To determine if MBL deficiency is a risk factor for SIDS.

Main Methods:

  • MBL concentrations were measured in 46 SIDS infants and 26 control infants.
  • Statistical analysis was performed to compare MBL levels between groups.

Main Results:

  • The proportion of infants with low MBL levels was similar in both SIDS and control groups.
  • The mean MBL concentration was significantly higher in the SIDS group (3 µg/ml) compared to the control group (2.2 µg/ml).

Conclusions:

  • The findings suggest that elevated MBL levels in SIDS infants may indicate an acute phase response to bacterial infection.
  • These results support the hypothesis that some SIDS cases might be preceded by bacterial infections, rather than MBL deficiency being a direct cause.

Related Concept Videos